We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Commercial Metals
CMC
$7.6B
| $6.09M | 0.08% |
449,804
+344,504
| +327% | +$5.26M |
|
|
RAD
252
PUT
DELISTED
Rite Aid Corporation
RAD
| $6.07M | 0.08% |
50,000
+49,500
| +9,900% | +$8.25M |
|
|
NATL
253
DELISTED
National Interstate Corporation
NATL
| $6M | 0.08% |
224,961
-19,765
| -8% | -$529K |
|
254
PUT
Viatris
VTRS
$20.4B
| $5.93M | 0.08% |
+147,400
| New | +$8.22M |
|
255
Mastercard
MA
$502B
| $5.86M | 0.08% |
65,029
+21,225
| +48% | +$1.99M |
|
256
Allstate
ALL
$68B
| $5.84M | 0.08% |
100,355
+94,075
| +1,498% | +$5.88M |
|
|
CY
257
DELISTED
Cypress Semiconductor
CY
| $5.79M | 0.08% |
680,079
-472,977
| -41% | -$4.96M |
|
|
STI
258
DELISTED
SunTrust Banks, Inc.
STI
| $5.79M | 0.08% |
151,300
+144,586
| +2,154% | +$6.05M |
|
259
Ameriprise Financial
AMP
$48.3B
| $5.75M | 0.08% |
52,741
-24,853
| -32% | -$2.93M |
|
260
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $5.75M | 0.08% |
30,000
+27,950
| +1,363% | +$5.67M |
|
261
Microsoft
MSFT
$3.45T
| $5.75M | 0.08% |
129,820
+108,800
| +518% | +$4.89M |
|
|
THOR
262
DELISTED
THORATEC CORPORATION
THOR
| $5.75M | 0.08% |
+90,812
| New | +$5.39M |
|
|
QUNR
263
DELISTED
Qunar Cayman Islands Limited
QUNR
| $5.71M | 0.08% |
190,000
+154,400
| +434% | +$5.64M |
|
264
Ulta Beauty
ULTA
$22B
| $5.7M | 0.08% |
34,901
-19,604
| -36% | -$3.23M |
|
265
G-III Apparel Group
GIII
$1.54B
| $5.67M | 0.08% |
91,912
-116,088
| -56% | -$7.97M |
|
266
Healthpeak Properties
DOC
$15.1B
| $5.66M | 0.08% |
166,789
+150,099
| +899% | +$5.19M |
|
267
James River Group Holdings
JRVR
$208M
| $5.65M | 0.08% |
210,103
-100,000
| -32% | -$2.71M |
|
268
Truist Financial
TFC
$63.3B
| $5.63M | 0.08% |
158,257
+12,746
| +9% | +$492K |
|
269
GSK
GSK
$104B
| $5.6M | 0.08% |
116,425
-17,876
| -13% | -$931K |
|
270
Regenxbio
RGNX
$620M
| $5.59M | 0.08% |
+253,923
| New | +$6.48M |
|
|
NGHC
271
DELISTED
National General Holdings Corp
NGHC
| $5.59M | 0.08% |
+290,000
| New | +$5.96M |
|
272
Charter Communications
CHTR
$17.3B
| $5.58M | 0.08% |
31,700
+27,371
| +632% | +$5M |
|
|
GNMK
273
DELISTED
GenMark Diagnostics, Inc
GNMK
| $5.49M | 0.08% |
697,413
+313,147
| +81% | +$2.9M |
|
|
WPX
274
DELISTED
WPX Energy, Inc.
WPX
| $5.47M | 0.07% |
+826,555
| New | +$6.91M |
|
275
lululemon athletica
LULU
$13.5B
| $5.47M | 0.07% |
107,938
-68,487
| -39% | -$4.17M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.